Testing effectiveness (Phase 2)Study completedNCT03126019What this trial is testingINCB050465 in Relapsed or Refractory Follicular LymphomaWho this might be right forLymphoma Incyte Corporation 126
Large-scale testing (Phase 3)Study completedNCT03976102What this trial is testingCompare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular LymphomaWho this might be right forFollicular Lymphoma Dr. Reddy's Laboratories Limited 317
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT04796857What this trial is testingTislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCLWho this might be right forNon-GCB/ABC Diffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma Grade IIIb+3 more Huiqiang Huang 30
Not applicableStudy completedNCT06798428What this trial is testingFor Grade I and II Knee Meniscal Injuries Patients ,Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis Will Be Used (A) Versus Placebo(B)Who this might be right forGrade I and II Knee Meniscal Injuries Eslam Elsayed Ali Shohda 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237What this trial is testingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT04850664What this trial is testingComputerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use DisorderWho this might be right forOpioid Use Disorder, ModerateOpioid Use Disorder, SevereWithdrawal Symptoms+2 more Evon Medics LLC 190
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT05543811What this trial is testingThe Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive PathologyWho this might be right forCognitive ChangeMemory; Disturbance, MildEmotional Regulation+1 more Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology 140
Testing effectiveness (Phase 2)Study completedNCT02723071What this trial is testingOcrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 48
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Active Not RecruitingNCT04447716What this trial is testingAn Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to TreatmentWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more Thomas Jefferson University 4
Not applicableNot Yet RecruitingNCT07092852What this trial is testingPGx Medication Safety Reviews of Persons With IDDWho this might be right forIntellectual Disability, MildIntellectual Disability, Mild to ModerateDevelopmental Disability GalenusRx, Inc. 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT05660967What this trial is testingSubcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Genmab 111
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Not applicableStudy completedNCT00261807What this trial is testingDaptomycin for the Treatment of Severe Necrotizing Soft-Tissue InfectionsWho this might be right forFasciitis, NecrotizingSevere Necrotizing Skin and Soft Tissue InfectionsFournier's Gangrene University of Maryland, Baltimore 25
Early research (Phase 1)Study completedNCT06535399What this trial is testingStudy to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentWho this might be right forHepatic ImpairmentHealthy Volunteers Celgene 29
Early research (Phase 1)UnknownNCT00008021What this trial is testingMonoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT01939899What this trial is testingPhase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular LymphomaWho this might be right forFollicular Lymphoma Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00021372What this trial is testingPaclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Fox Chase Cancer Center 25